MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dystonia: Treatment"

  • 2017 International Congress

    Onabotulinumtoxin A (Botox) displays superior activity to incobotulinumtoxinA (Xeomin) in multiple in vitro and in vivo assays

    D. Canty, L. Le, J. Wang, G. Nicholson, A. Brideau-Andersen, L. Steward, B. Jacky, R. Broide, M. Washburn, D. Rupp (Irvine, CA, USA)

    Objective: This study was conducted to assess in vivo and in vitro activity of 50 U, 100 U, and 200 U vials of incobotulinumtoxinA (Merz,…
  • 2017 International Congress

    Clinical analysis of patients with servical dystonia who Botulinum toxin injection is performed: 10 years experience of Ege University Neurology Department of Movement Disorders Clinic

    A. Acarer, S. Ciftci, Z. Colakoglu (Izmir, Turkey)

    Objective: In this study, it is aimed to analysis of clinical features and  treatment efficiency  in patients with servical dystonia who are performed Botulinum injection…
  • 2016 International Congress

    Recharge frequency is not driven by therapy power usage in patients implanted with rechargeable deep brain stimulation systems

    T. Weaver, P. Konrad, L. Timmerman, G. Molnar, K. Stromberg (Minneapolis, MN, USA)

    Objective: To explore the relationship between recharge frequency and therapy power usage in patients with rechargeable deep brain stimulation (DBS) devices. Background: Advancements in DBS…
  • 2016 International Congress

    DBS outcomes in a mixed cohort of dystonia: A single center experience

    O. Saeed, I. Haq, S.B. Tatter, A.W. Laxton, T. Wilson, M. Siddiqui (Winston Salem, NC, USA)

    Objective: To evaluate the efficacy and complications of deep brain stimulation (DBS) of globus pallidus interna (GPi) in a mixed cohort of dystonia patients. Background:…
  • 2016 International Congress

    Pallidal deep brain stimulation improves dystonia in Woodhouse-Sakati syndrome

    J.Y. Chen, J.L. Ostrem, B. Lee, P. Starr, A. Viehoever (San Francisco, CA, USA)

    Objective: To describe a patient with a rare genetic disorder, Woodhouse-Sakati Syndrome, treated with deep brain stimulation (DBS) for dystonia. Background: Woodhouse-Sakati Syndrome (WSS) is…
  • 2016 International Congress

    Efficacy of 4845 botulinum toxin (BoNT) treatment cycles, and clinical strategies after a failed cycle

    P. Tanvijit, A.P. Moore (Bangkok, Thailand)

    Objective: To explore 1) relationship between peak benefit and Duration of Adequate Response (DAR) after BoNT, 2) frequency & causes of secondary Treatment Failure (TF),…
  • 2016 International Congress

    Bacterial biofilm formation on neurostimulation systems

    A. Wloch, B. Hong, M. Abdallat, A. Winkel, A. Saryyeva, G. Lütjens, M. Stiesch, J.K. Krauss (Hannover, Germany)

    Objective: The aim of this study is to identify specifically the DNA of bacterial biofilm on neurostimulation systems using polymerase chain reaction (PCR). Background: Bacterial…
  • 2016 International Congress

    Phenomenology of idiopathic adult-onset truncal dystonia

    D.J. Ehrlich, S.J. Frucht (New York, NY, USA)

    Objective: Characterize the phenomenology and natural history of adult onset idiopathic truncal dystonia. Background: Focal dystonias are the most common type of adult-onset dystonia, however,…
  • 2016 International Congress

    Synergistic effects of physical therapy and botulinum toxin in primary cervical dystonia

    W. Hu, V. Rundle-Gonzalez, S.J. Kulkarni, L. Almeida, M. Okun, A. Wagle Shukla (Gainesville, FL, USA)

    Objective: To compare standard botulinum toxin (BoNT) versus physical therapy (PT) combined with BoNT in primary cervical dystonia (PCD). Background: PCD is frequently a source…
  • 2016 International Congress

    Significant improvement of adult-onset dystonia with cannabinoids-based oromucosal spray

    M. Aguilar, S. Romero, L. Molina Porcel, P. Pastor (Terrassa, Spain)

    Objective: We performed an open study of delta-9-tetrahydrocannabinol and cannabidiol (THC:CBD) oromucosal spray (Nabiximols, Sativex®) in 6 patients with suboptimal responsive adult-onset dystonia. Background: Cannabinoids…
  • « Previous Page
  • 1
  • …
  • 32
  • 33
  • 34
  • 35
  • 36
  • …
  • 39
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley